Emyria LtdASX: EMD

Emyria & UWA Partner to License Novel Serotonin Therapies

· Issued by Emyria Ltd

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Emyria Ltd has announced an exclusive licence agreement with the University of Western Australia, granting worldwide rights to a portfolio of serotonin-releasing agents aimed at treating mental health and neurological conditions. This partnership is supported by a government grant and aims to enhance treatment outcomes while minimizing side effects associated with existing therapies.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Emyria Ltd on 6ix

Earlier from Emyria

Later from Emyria

All Emyria news releases